Sara Anastasio, APRN, RN
Staff Affiliate - YNHHDownloadHi-Res Photo
Cards
Contact Info
About
Copy Link
Titles
Staff Affiliate - YNHH
Departments & Organizations
- Yale Cancer Center
- Yale Medicine
- Yale New Haven Health System
Research
Copy Link
Clinical Trials
Current Trials
Phase 2 Study of Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory CD30 Positive T-cell Lymphoma
IRB ID2000029793RoleSub InvestigatorPrimary Completion Date04/30/2028Recruiting ParticipantsRandomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
IRB ID2000032879RoleSub InvestigatorPrimary Completion Date12/31/2026Recruiting ParticipantsRandomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High-Risk Pancreatic Neuroendocrine Tumors
IRB ID2000032098RoleSub InvestigatorPrimary Completion Date03/31/2025Recruiting ParticipantsA Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in Patients With Relapse or Refractory Peripheral T-cell Lymphoma (PTCL)
IRB ID2000030190RoleSub InvestigatorPrimary Completion Date06/02/2026Recruiting ParticipantsDaratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
IRB ID2000025737RoleSub InvestigatorPrimary Completion Date12/31/2029Recruiting Participants
Get In Touch
Copy Link
Contacts
Appointment Number